25 items of Pfizer Korea are subject to suspension of manufacturing business
Published: 2002-08-22 06:57:00
Updated: 2002-08-22 06:57:00
In line with the recent controversy on the mixed packaging of both Cardura(doxazosin mesylate) and Cofrel (benproperine phosphate), 25 items of Pfizer Korea including Norvasc (amlodipine besylate) will subject to the prior notice for administrative disposition.
In its notice to Pfizer Korea on...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
